Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy
PD1/IL15 的转化 PK/PD 和首次人体剂量选择:用于癌症免疫治疗的工程重组靶向细胞因子
期刊:Frontiers in Pharmacology
影响因子:4.4
doi:10.3389/fphar.2024.1380000
Rajbharan Yadav #, Suzanne Schubbert #, Patrick G Holder, Eugene Y Chiang, Nargess Kiabi, Liz Bogaert, Irene Leung, Rumana Rashid, Kendra N Avery, Christine Bonzon, John R Desjarlais, Shomyseh Sanjabi, Amy Sharma, Michelle Lepherd, Amy Shelton, Pam Chan, Yanqiu Liu, Louis Joslyn, Iraj Hosseini, Eric